Advertisement
Advertisement

SNOA

SNOA logo

Sonoma Pharmaceuticals, Inc. Common Stock

3.09
USD
Sponsored
+0.03
+0.98%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

3.03

-0.06
-2.07%

SNOA Earnings Reports

Positive Surprise Ratio

SNOA beat 11 of 21 last estimates.

52%

Next Report

Date of Next Report
Jun 15, 2026
Estimate for Q4 26 (Revenue/ EPS)
$4.68M
/
-$0.20
Implied change from Q3 26 (Revenue/ EPS)
--
/
--
Implied change from Q4 25 (Revenue/ EPS)
--
/
--

Sonoma Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Feb 03, 2026, SNOA reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -0.31 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 4.41 million, with a --% difference. The market reacted with a -0.93% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 3 analysts forecast an EPS of -0.20 USD, with revenue projected to reach 4.68 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2026, Sonoma Pharmaceuticals, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved down -0.93%, changed from $3.23 before the earnings release to $3.20 the day after.
The next earning report is scheduled for Jun 15, 2026.
Based on 3 analysts, Sonoma Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.20 and revenue of $4.68M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement